Menu
Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,076 | Dovepress* | 6,604+ | 1,343 | 7,947 | |
| PubMed Central* | 472 | 159 | 631 | ||
| Totals | 7,076 | 1,502 | 8,578 | ||
| *Since 14 October 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar